---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-030088"
form_type: "8-K"
ticker: "GNPX"
cik: "0001595248"
company_name: "Genprex, Inc."
filed_at: "2024-09-26T23:59:59+00:00"
generated_at: "2026-05-31T01:33:32.420982+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Genprex receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period

## Summary
- Nasdaq letter dated Sept 26, 2024; stock fails minimum $1.00 bid price for 30 consecutive business days.
- Cure period ends March 25, 2025; must have $1.00 closing bid for 10 consecutive days to regain compliance.
- Company may qualify for additional 180-day period if it meets other listing standards and notifies Nasdaq.
- Potential actions include reverse stock split; delisting risk if unable to cure.
- Common stock continues trading on Nasdaq Capital Market while Company monitors bid price.

## SEC filing metadata
- accession: 0001437749-24-030088
- form_type: 8-K
- ticker: GNPX
- cik: 0001595248
- company_name: Genprex, Inc.
- filed_at: 2024-09-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595248/000143774924030088/0001437749-24-030088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595248/000143774924030088/gnpx20240920_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-030088
- JSON: https://secwatch.observer/filing/0001437749-24-030088.json
- Plain text: https://secwatch.observer/filing/0001437749-24-030088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.